Trijardy XR 5 mg/1 (Empagliflozin, Linagliptin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 5 mg/1

Trijardy XR 5 mg/1 is an extended-release tablet combining empagliflozin, linagliptin, and metformin hydrochloride. It is designed to support glucose management in adults with type 2 diabetes. This medication is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. in the USA.

Strength

5 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0597-0390-31) / 7 TABLET, EXTENDED RELEASE in 1 BOTTLE

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trijardy XR 5 mg/1 is primarily used for managing blood sugar levels in adults with type 2 diabetes. The combination of empagliflozin, linagliptin, and metformin hydrochloride works to improve glycemic control. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise.

Side Effects

Common effects of Trijardy XR 5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some individuals may also experience urinary tract infections or hypoglycemia, especially when combined with other diabetes medications. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Trijardy XR 5 mg/1 should be handled with care, especially for individuals with a history of kidney problems, as empagliflozin can affect kidney function. Metformin hydrochloride may not be suitable for those with severe liver disease. Always follow the advice of a healthcare professional regarding the use of this medication, particularly if you have other medical conditions or are taking other medications.

Avoid Interactions

Trijardy XR 5 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis with metformin. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Trijardy XR 5 mg/1 is used to manage blood sugar levels in adults with type 2 diabetes.

Trijardy XR 5 mg/1 is an oral medication that should be taken as directed by a healthcare provider, typically with food to minimize gastrointestinal side effects.

Common side effects may include gastrointestinal discomfort, urinary tract infections, and hypoglycemia.

Trijardy XR 5 mg/1 may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Trijardy XR 5 mg/1 may not be suitable for individuals with certain medical conditions, such as severe kidney or liver disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.